(index price) (total return)
Jefferies Smallcap Biopharma IndexSM is intended to reflect the stock performance of smallcap biotech and pharmaceutical stocks listed on the Nasdaq, NYSE and AMEX with market capitalization between $100 million and $1 billion. The eligible constituents follow the definitions presented by the Global Industry Classification Standard ("GICS") sub-industries Biotechnology and Pharmaceuticals. The constituents are then subject to market capitalization and liquidity requirements. The methodologies for index construction and the universe of eligible constituents are defined by Jefferies in consultation with Standard & Poor's, while the calculation and maintenance of the index are completed by Standard & Poor's.
Index Methodology (pdf)
Index Total Return Performance
Current Constituents and Weighting (last updated 09-05-08)
| ALPHARMA Inc. | ALO | 4.8% |
| Medicines Company | MDCO | 4.0% |
| Martek Biosciences | MATK | 3.7% |
| ViroPharma Inc | VPHM | 3.2% |
| Sciele Pharma, Inc. | SCRX | 3.1% |
| Incyte Corporation | INCY | 3.0% |
| Acorda Therapeutics Inc | ACOR | 3.0% |
| Savient Pharmaceuticals | SVNT | 2.9% |
| Rigel Pharmaceuticals Inc | RIGL | 2.8% |
| Cv Therapeutics Inc | CVTX | 2.2% |
| Seattle Genetics Inc /Wa | SGEN | 2.0% |
| Halozyme Therapeutics Inc Com | HALO | 1.9% |
| Vivus Inc | VVUS | 1.9% |
| Intermune Inc | ITMN | 1.8% |
| Par Pharmaceutical Cos. | PRX | 1.8% |
| Dendreon Corp | DNDN | 1.7% |
| Durect Corporation | DRRX | 1.4% |
| Arena Pharmaceuticals Inc | ARNA | 1.4% |
| Allos Therapeutics Inc | ALTH | 1.2% |
| Progenics Pharmaceuticals Inc | PGNX | 1.2% |
| Geron Corp | GERN | 1.1% |
| NPS Pharmaceuticals | NPSP | 1.1% |
| Sangamo BioSciences Inc | SGMO | 1.1% |
| Gtx Inc | GTXI | 1.0% |
| Questcor Pharmaceuticals Inc Com | QCOR | 1.0% |
| View all constituents |